Head covering effects on serm calcium during phototherapy

Head covering during phototherapy appropriate and safe method for Prevention of phototherapy-induced hypocalcaemia in icterus newborn with unaltered serum magnesium level.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013102315134N1

Enrollment

Registered

2014-01-08

Start date

2010-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice. Haemorrhagic and haematological disorders of fetus and newborn

Interventions

Intervention 1: Case group intervention: The occipital area of this group during phototherapy was covered by a hat. Calcium and magnesium levels were checked at the beginning, 48 hours after starting

Prevention

Case group intervention: The occipital area of this group during phototherapy was covered by a hat. Calcium and magnesium levels were checked at the beginning, 48 hours after starting phototherapy, an

Control group intervention: Routine phototherapy was used for first group. Calcium and magnesium levels were checked at the beginning, 48 hours after starting phototherapy, and 24 hours after the tr

Eligibility

Sex/Gender

All

Age

3 Years to 5 Years

Inclusion criteria

Inclusion criteria: The major including criteria were : Full term; Weighed more than 2500 grams; Had normal serum calcium; Apart from icterus; indirect bilirubin between13 to 18 mg/dl in full term neonates - their physical status was completely normal. The major excluding criteria were: Asphyxia; respiratory distress; sepsis; hemolytic anemia; infants of mothers with diabetic or thyroid disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Bilirubin. Timepoint: The bilirubin level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.;Calcium. Timepoint: The calcium level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.;Magnesium. Timepoint: The calcium level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.	—

Measure

Time frame

Bilirubin. Timepoint: The bilirubin level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.;Calcium. Timepoint: The calcium level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.;Magnesium. Timepoint: The calcium level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Kargar

Shiraz University of Medical Sciences

kargarm@sums.ac.ir+98 71 1647 4252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026